SCHEMBL5024671

SCHEMBL5024671

C[C@@H]1NC[C@H]2C[C@@]21c1ccc(Cl)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 17/20 0.48
SLC6A4 P31645 17/20 0.48
SLC6A3 Q01959 17/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KCNH2 Q12809 1/20 0.48
CHRNA1 P02708 1/20 0.43
CHRNG P07510 1/20 0.43
CHRNB1 P11230 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
CHRND Q07001 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14124619 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL14124621 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4189839 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4174019 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4184515 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL13698233 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL13698028 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4174016 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL13698030 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4
SCHEMBL4184518 1.00 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915146-A2 NOVEL 1-ARYL-3-AZABICYCLOÝ3.1.0¨HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV Pharmaceutical, Inc. (US) 2008-04-30 EP claimed
WO-2007016155-A2 NOVEL 1-ARYL-3-AZABICYCLO[3.1.0]HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV PHARMACEUTICAL, INC. (US) 2007-02-08 WO claimed
EP-1915146-A2 NOVEL 1-ARYL-3-AZABICYCLOÝ3.1.0¨HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV Pharmaceutical, Inc. (US) 2008-04-30 EP disclosed
WO-2007016155-A2 NOVEL 1-ARYL-3-AZABICYCLO[3.1.0]HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS DOV PHARMACEUTICAL, INC. (US) 2007-02-08 WO disclosed